Cookies on our website

We use cookies on our website. To learn more about cookies, how we use them on our site and how to change your cookie settings please view our cookie policy.

Read more Close
Skip Ribbon Commands
Skip to main content
You searched for:
Search

Search

1-2 of 2 results
Results per page: 
Sort by: 
Allen & Overy has advised science-based pharmaceutical company Grünenthal on its acquisition of AstraZeneca’s European rights to prescription Nexium and the global (excluding the US and Japan) rights . Allen & Overy has advised science-based pharmaceutical company Grünenthal on its acquisition of
30 October 2018
http://www.allenovery.com/news/en-gb/articl … -with-AstraZeneca-for-Nexium-and-Vimovo.aspx
Allen & Overy has advised the founders and shareholders of Walmark, Czech manufacturer of dietary supplements, OTC pharmaceuticals and other related products with subsidiaries in 10 other European countries, on the 50% capital entry by Mid Europa Partners, one of the leading private equity funds in
17 August 2012
http://www.allenovery.com/news/en-gb/articles/Pages/Walmark-Mid Europa.aspx


  • Add comment (optional)